101 related articles for article (PubMed ID: 16373855)
1. Phenotypic diversity of the lung vasculature in experimental models of metastases.
Oh Y; Mohiuddin I; Sun Y; Putnam JB; Hong WK; Arap W; Pasqualini R
Chest; 2005 Dec; 128(6 Suppl):596S-600S. PubMed ID: 16373855
[TBL] [Abstract][Full Text] [Related]
2. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display.
Rajotte D; Ruoslahti E
J Biol Chem; 1999 Apr; 274(17):11593-8. PubMed ID: 10206967
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
Rajotte D; Arap W; Hagedorn M; Koivunen E; Pasqualini R; Ruoslahti E
J Clin Invest; 1998 Jul; 102(2):430-7. PubMed ID: 9664085
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor vasculature with homing peptides from phage display.
Ruoslahti E
Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
[TBL] [Abstract][Full Text] [Related]
5. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
6. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
Matsuo AL; Juliano MA; Figueiredo CR; Batista WL; Tanaka AS; Travassos LR
Mol Cancer Res; 2011 Nov; 9(11):1471-8. PubMed ID: 21900362
[TBL] [Abstract][Full Text] [Related]
7. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
8. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
[TBL] [Abstract][Full Text] [Related]
9. Identification of homing peptides using the in vivo phage display technology.
Rivinoja A; Laakkonen P
Methods Mol Biol; 2011; 683():401-15. PubMed ID: 21053146
[TBL] [Abstract][Full Text] [Related]
10. Vascular targeting with phage peptide libraries.
Pasqualini R
Q J Nucl Med; 1999 Jun; 43(2):159-62. PubMed ID: 10429511
[TBL] [Abstract][Full Text] [Related]
11. Vascular zip codes in angiogenesis and metastasis.
Ruoslahti E
Biochem Soc Trans; 2004 Jun; 32(Pt3):397-402. PubMed ID: 15157146
[TBL] [Abstract][Full Text] [Related]
12. [In-vivo screening and characterization of peptides specific for vasculature of gastric cancer].
Wang Y; Wu KC; Nie YZ; Han ZY; Han QL; Qiao TD; Fan DM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):469-72. PubMed ID: 15169660
[TBL] [Abstract][Full Text] [Related]
13. Prevention of melanoma metastases in lungs of BAT treated and peptide immunized mice.
Feinmesser M; Raiter A; Hardy B
Int J Oncol; 2006 Oct; 29(4):911-7. PubMed ID: 16964387
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial ligand-directed lung targeting.
Giordano RJ; Edwards JK; Tuder RM; Arap W; Pasqualini R
Proc Am Thorac Soc; 2009 Aug; 6(5):411-5. PubMed ID: 19687212
[TBL] [Abstract][Full Text] [Related]
15. Molecular addresses of tumors: selection by in vivo phage display.
Li XB; Schluesener HJ; Xu SQ
Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
[TBL] [Abstract][Full Text] [Related]
16. Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo.
Yang Yu ; Zizheng Wang ; Tongxin Du
J Biomol Screen; 2008 Dec; 13(10):968-74. PubMed ID: 18978306
[TBL] [Abstract][Full Text] [Related]
17. In vivo phage display--a discovery tool in molecular biomedicine.
Bábíčková J; Tóthová Ľ; Boor P; Celec P
Biotechnol Adv; 2013 Dec; 31(8):1247-59. PubMed ID: 23623852
[TBL] [Abstract][Full Text] [Related]
18. Peptide targeting of tumor lymph vessels.
Laakkonen P; Zhang L; Ruoslahti E
Ann N Y Acad Sci; 2008; 1131():37-43. PubMed ID: 18519957
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell-based systemic gene therapy of metastatic melanoma.
Ojeifo JO; Lee HR; Rezza P; Su N; Zwiebel JA
Cancer Gene Ther; 2001 Sep; 8(9):636-48. PubMed ID: 11593332
[TBL] [Abstract][Full Text] [Related]
20. Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis.
Guan YY; Luan X; Xu JR; Liu YR; Lu Q; Wang C; Liu HJ; Gao YG; Chen HZ; Fang C
Biomaterials; 2014 Mar; 35(9):3060-70. PubMed ID: 24393268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
